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Purpose of the study
Pregnancy is nowadays a viable option for many HIV-pos-
itive women. The purpose of this study was to describe ret-
rospectively HIV-positive pregnant women who were
followed up at ITM in Antwerp, and to assess the outcome
of their pregnancies and risk factors for adverse outcome.
Methods
Data from HIV-positive women with reported pregnancy
were extracted from the clinical database at ITM. Socio-
demographic and clinical data were analysed for all
patients. Analysis of pregnancy outcome was restricted to
singleton deliveries.
Summary of results
A total of 168 pregnancies in 127 women were followed
up between 1997 and 2007. The women delivered 171
babies (three sets of twins). Thirty women had two preg-
nancies, four had three pregnancies and one woman
delivered four times. The majority of women (76.4%)
were from sub-Saharan Africa. Mean age was 30 years
(17–42). Fifty-five women (43%) were unaware of their
HIV status prior to the pregnancy that was registered at
ITM and 93% had acquired HIV through heterosexual
contact. Three patients (2.4%) were infected with HIV-2,
one (0.8%) had a dual infection.
CD4 count prior to delivery was =<200 cells/mm3 in 6.8%
of patients, between 200 and 350 in 16.7% of women,
and >350 in 76.5% of patients. In 56 pregnancies, the
women were on antiretroviral therapy prior to their preg-
nancy, in 106 pregnancies therapy was started (at a mean
gestational age of 23 weeks) and in four pregnancies no
treatment was taken during pregnancy. Treatment during
pregnancy was HAART in 130 (80.2%) of cases, AZT mon-
otherapy in 17 (10.5%), and dual therapy in 15 (9.3%).
Of the women on treatment, 84.9% had a viral load of less
than 500 copies/ml prior to delivery, 1.9% had 500–1000
copies/ml, and 13.2% more than 1,000 copies/ml.
A total of 165 deliveries were singleton and were analysed
on pregnancy outcome. 70.9% were deliveries by Caesar-
ean section of which 67.5% were planned; and 23.0%
were vaginal deliveries. For the remainder 6.1%, no data
were available. Twenty-two babies (13.3%) were prema-
ture babies. Of the 121 babies whose birth-weight was
recorded (the 44 missing birth-weights were not from pre-
mature babies), 22 babies (18.2%) had a low birth-weight
(<2500 g) of which four were very low birth-weight <1000
g. HIV transmission was diagnosed in one newborn.
Conclusion
HIV transmission from mothers to their babies is very rare
in industrialized countries, but other adverse pregnancy
outcomes remain a problem. Rates of prematurity and
low birth-weight are substantially higher in HIV-infected
women.
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